Subotheni Thavaneswaran

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Genome Wide Analysis

Induced Pluripotent Stem Cells

Epidermal Growth Factor Receptor

Top Venues

JCO precision oncology

British journal of cancer

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Subotheni Thavaneswaran, Frank Po-Yen Lin, John P Grady, David Espinoza, Min Li Huang, Sarah Chinchen, Lucille Sebastian, Maya Kansara, Tony Mersiades, Chee Khoon Lee, Jayesh Desai, Peter Grimison, Michael Brown, Michael Millward, Rosemary Harrup, Ken O'Byrne, Adnan Nagrial, Paul Craft, R John Simes, Anthony M Joshua, David M Thomas
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation. NPJ precision oncology 8 (1) (2024)
Subotheni Thavaneswaran, Maya Kansara, Frank Lin, David Espinoza, John P Grady, Chee Khoon Lee, Mandy L Ballinger, Lucille Sebastian, Theresa Corpuz, Min Ru Qiu, Piyushkumar Mundra, Charles G Bailey, Ulf Schmitz, John Simes, Anthony M Joshua, David M Thomas
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations. British journal of cancer (2023)
Subotheni Thavaneswaran, Wei Yen Chan, Ray Asghari, John P Grady, Maegan Deegan, Valerie M Jansen, David M Thomas
Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an NRG1 Fusion. JCO precision oncology 6 (2022)